SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-22-006437
Filing Date
2022-01-21
Accepted
2022-01-21 15:19:19
Documents
1
Group Members
DR. JAMES I. HEALYDR. MAHA KATABISOFINNOVA MANAGEMENT X, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D tm224128-1_sc13d.htm SC 13D 107874
  Complete submission text file 0001104659-22-006437.txt   109451
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners X, L.P. (Filed by) CIK: 0001680200 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 8445311834
CinCor Pharma, Inc. (Subject) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93228 | Film No.: 22545757
SIC: 2834 Pharmaceutical Preparations